Compounded Injectable Safety Alerts Cite Sterility Concerns for Semaglutide, Tirzepatide, and Sermorelin
Patients who have received compounded injectable medications — specifically semaglutide, tirzepatide, or sermorelin — from a pharmacy connected to recent safety alerts should contact their prescribing clinician or dispensing pharmacy promptly to